$VRTX VERTEX PHARMACEUTICALS INC / MA Insider Trading Week 46/2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA in week 46/2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 63.14 | 7,500 | 473,550 | 7,500 | |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 72.14 | 7,500 | 541,050 | 12,500 | |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 130.00 | 15,000 | 1,950,000 | 75,000 | 90 K to 75 K (-16.67 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 63.14 | 7,500 | 473,550 | 90,000 | 82.5 K to 90 K (+9.09 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 72.14 | 7,500 | 541,050 | 82,500 | 75 K to 82.5 K (+10.00 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 130.00 | 16,125 | 2,096,250 | 217,902 | 234 K to 217.9 K (-6.89 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 73.51 | 10,315 | 758,256 | 30,938 | |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 130.00 | 10,315 | 1,340,950 | 100,562 | 110.9 K to 100.6 K (-9.30 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 73.51 | 10,315 | 758,256 | 110,877 | 100.6 K to 110.9 K (+10.26 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 57.27 | 12,500 | 715,875 | 0 | |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 130.15 | 12,500 | 1,626,875 | 1,088 | 13.6 K to 1.1 K (-91.99 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Buy | M | 57.27 | 12,500 | 715,875 | 13,588 | 1.1 K to 13.6 K (+1,148.90 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 35.64 | 10,400 | 370,656 | 104,800 | |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 133.03 | 400 | 53,212 | 345,284 | 345.7 K to 345.3 K (-0.12 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 132.44 | 3,300 | 437,052 | 345,684 | 349 K to 345.7 K (-0.95 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 131.55 | 3,100 | 407,805 | 348,984 | 352.1 K to 349 K (-0.88 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 130.25 | 800 | 104,200 | 352,084 | 352.9 K to 352.1 K (-0.23 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 128.96 | 2,800 | 361,088 | 352,884 | 355.7 K to 352.9 K (-0.79 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 35.64 | 10,400 | 370,656 | 355,684 | 345.3 K to 355.7 K (+3.01 %) |
Nov 18 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 122.28 | 85 | 10,394 | 78,963 | 79 K to 79 K (-0.11 %) |
Nov 18 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 123.00 | 1 | 123 | 14,937 | 14.9 K to 14.9 K (-0.01 %) |
Nov 18 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 122.31 | 127 | 15,533 | 14,938 | 15.1 K to 14.9 K (-0.84 %) |
Nov 18 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 77.31 | 3,650 | 282,182 | 38,250 | |
Nov 18 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 124.00 | 3,650 | 452,600 | 104,464 | 108.1 K to 104.5 K (-3.38 %) |
Nov 18 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 123.00 | 100 | 12,300 | 108,114 | 108.2 K to 108.1 K (-0.09 %) |
Nov 18 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 122.47 | 143 | 17,513 | 108,214 | 108.4 K to 108.2 K (-0.13 %) |
Nov 18 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 121.95 | 184 | 22,439 | 108,357 | 108.5 K to 108.4 K (-0.17 %) |
Nov 18 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 77.31 | 3,650 | 282,182 | 108,541 | 104.9 K to 108.5 K (+3.48 %) |